About this trial
This study aims to investigate the causal relationship between plasma vascular endothelial growth factor (VEGF) family proteins and placenta previa using a two-sample Mendelian randomization (MR) approach. Genome-wide association study (GWAS) data will be analyzed to assess the correlation and potential causality between VEGF protein levels and the occurrence of placenta previa.
Eligibility criteria
Qualifiers
Participants included in genome-wide association studies (GWAS) with available data on plasma VEGF family proteins and placenta previa.
Disqualifiers
Participants with incomplete or missing data on plasma VEGF levels or placenta previa.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Guangzhou Institute of Respiratory Disease
Lead sponsor
The Second People's Hospital of Foshan
Collaborator
First People's Hospital of Foshan
Collaborator
Maternal and Child Health Hospital of Foshan
Collaborator